HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Artificial Pancreas and Closed-Loop Systems

Advancements in artificial pancreas and closed-loop systems are revolutionizing diabetes care by automating glucose regulation. These systems integrate continuous glucose monitors with insulin pumps, enabling real-time adjustments based on glucose fluctuations. Hybrid closed-loop models have significantly improved glycemic control, reducing the burden of frequent insulin adjustments. Innovations in dual-hormone systems, incorporating glucagon alongside insulin, aim to further enhance stability and minimize hypoglycemia risks. While current technology continues to evolve, challenges such as sensor accuracy, accessibility, and cost remain. With ongoing development, fully automated, next-generation artificial pancreas systems are expected to provide more precise, user-friendly solutions for diabetes management.

Committee Members
Speaker at Diabetes and Endocrinology 2025 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical Center, United States
Speaker at Diabetes and Endocrinology 2025 - F Buck Willis

F Buck Willis

IUHS School of Medicine, Saint Kitts and Nevis
Speaker at Diabetes and Endocrinology 2025 - Gretchen Holmes

Gretchen Holmes

Memorial Hospital at Gulfport, United States
Diabetes 2025 Speakers
Speaker at Diabetes and Endocrinology 2025 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes and Endocrinology 2025 - Amy Gutman

Amy Gutman

AdventHealth; Tough Love MD, United States
Speaker at Diabetes and Endocrinology 2025 - Paraskevi Theofilou

Paraskevi Theofilou

Hellenic Open University, Greece
Speaker at Diabetes and Endocrinology 2025 - Clifford Morris

Clifford Morris

Kihealth, United States
Tags

Submit your abstract Today

Watsapp